Zacks Investment Management Has $1.17 Million Position in Phreesia, Inc. (NYSE:PHR)

Zacks Investment Management boosted its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 67.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,411 shares of the company's stock after purchasing an additional 18,710 shares during the quarter. Zacks Investment Management owned 0.08% of Phreesia worth $1,168,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. R Squared Ltd acquired a new stake in Phreesia during the 4th quarter worth $30,000. BankPlus Trust Department bought a new stake in shares of Phreesia in the fourth quarter worth about $34,000. Venturi Wealth Management LLC acquired a new stake in shares of Phreesia during the fourth quarter worth about $76,000. Smartleaf Asset Management LLC lifted its holdings in shares of Phreesia by 154.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after purchasing an additional 2,090 shares in the last quarter. Finally, NewEdge Advisors LLC grew its position in shares of Phreesia by 12.1% in the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after purchasing an additional 459 shares during the period. Institutional investors own 92.10% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on PHR. KeyCorp cut their price objective on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Piper Sandler reissued an "overweight" rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Citigroup raised their price objective on Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research report on Friday, January 10th. Royal Bank of Canada raised shares of Phreesia from a "sector perform" rating to an "outperform" rating and increased their price target for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research report on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia currently has a consensus rating of "Buy" and a consensus price target of $31.33.

Insider Buying and Selling

In other news, SVP David Linetsky sold 4,499 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the transaction, the senior vice president now owns 217,239 shares in the company, valued at approximately $5,155,081.47. The trade was a 2.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Allison C. Hoffman sold 1,213 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total transaction of $28,881.53. Following the completion of the transaction, the general counsel now owns 137,921 shares in the company, valued at $3,283,899.01. This trade represents a 0.87 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 147,057 shares of company stock worth $4,070,658 in the last ninety days. Company insiders own 5.80% of the company's stock.

Phreesia Trading Up 1.8 %

NYSE:PHR traded up $0.44 during mid-day trading on Thursday, hitting $24.62. 64,742 shares of the company's stock were exchanged, compared to its average volume of 471,543. The company has a 50 day simple moving average of $25.72 and a 200-day simple moving average of $24.32. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The firm has a market capitalization of $1.45 billion, a P/E ratio of -16.75 and a beta of 0.82.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.